In terms of work carried out towards the objectives specified in the Draft of Action (DoA), timing, task completion, deliverables submission and achievements of mile-stones, communication/dissemination and KPIs, REACH progressed fully in Report-ing Period 3 according to schedule.
REACH achieves its objectives through highly integrated and personalized sensing-monitoring-intervention chains representing comprehensive solutions that are exem-plarily and iteratively adapted in the project to the ecosystems of a series of care set-tings throughout Europe (homes, hospitals, care homes, day care facilities, communi-ties, etc.) for older individuals. REACH implements, demonstrates, tests, and vali-dates (by more than 30 small- to medium-sized trials) through those settings, customized and personalized instances of this chain. A unique feature of REACH is the inte-grated utilization of digitally enabled and personalized behavior change and user en-gagement techniques informing about the development of the products and solutions (sensors, interfaces, devices, etc.).
REACH implements a combination of wearable and ambient sensors for each Touch-point along with a set of co-adapted Machine Learning elements. Machine Learning is used as a core element in multiple ways, for instance, to predict Activities of Daily Liv-ing (ADLs), recognize physical activity and behavior trends, detect deviations of pat-terns and critical situations, cluster and profile individuals, and inform the effective-ness of the assignment of certain interventions. Personalized Intelligent Interior Units (PI²Us, i.e. smart furniture devices) are used to seamlessly integrate the aforemen-tioned functional elements into daily life in the different target use case settings. Last but not least, REACH has developed practices and schematics to assess the implica-tions of the use of its solutions with regard to privacy, legal, and ethical aspects in or-der to ensure technology acceptance by end-users, caregivers, and other care and medical professionals.
In Reporting Period 3, we have worked systematically towards commercialization aspects in order to foster the developed solutions to go successfully through the so called “valley of death” in terms of innovation. REACH sharpened the medical pur-pose of its solutions, developed a regime for motivational market segmentation, and worked with a series of practice cases and demonstrations toward clarifying value chains and business procedures.
